List of insiders holdings for TELA Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | EW HEALTHCARE PARTNERS FUND 2 L.P. EW HEALTHCARE PARTNERS FUND 2-A L.P. EW Healthcare Partners Fund 2 GP L.P. EW Healthcare Partners Fund 2-UGP LLC See Remarks 10% Owner | 2026-06-09 18:29:21 | 7,714,709 0 | 7,714,709 | Form 13D |
| 2 | Opaleye Management Inc. Former 10% Owner. | 2023-04-20 16:05:29 | 0 2,072,813 | 2,072,813 | Form 4 |
| 3 | ORBIMED ADVISORS LLC OrbiMed Capital GP IV LLC 10% Owner | 2024-10-25 16:24:30 | 1,182,717 0 | 1,182,717 | Form 13D |
| 4 | KOBLISH ANTONY Chief Executive Officer | 2026-02-24 20:01:54 | 847,210 0 | 847,210 | Form 4 |
| 5 | Ellis Ronald J. Jr. Pacira BioSciences Inc. Director 10% Owner | 2019-11-13 21:06:16 | 0 774,056 | 774,056 | Form 4 |
| 6 | Friedman Ashley Director | 2019-11-13 20:48:59 | 0 684,948 | 684,948 | Form 4 |
| 7 | Zuga Matt Director | 2019-11-13 20:57:28 | 0 623,924 | 623,924 | Form 4 |
| 8 | Getz Heather C Chief Executive Officer | 2026-08-19 16:10:13 | 532,500 0 | 532,500 | Form 4 |
| 9 | RTW INVESTMENTS LP WONG RODERICK 10% Owner | 2023-02-14 10:10:15 | 390,364 0 | 390,364 | Form 13G |
| 10 | Cuca Roberto COO and CFO | 2026-02-24 20:00:16 | 342,377 0 | 342,377 | Form 4 |
| 11 | Blizard Jeffrey President | 2026-02-24 20:00:15 | 332,125 0 | 332,125 | Form 4 |
| 12 | Talmo Paul Chief Technology Officer | 2026-02-24 20:00:18 | 258,436 0 | 258,436 | Form 4 |
| 13 | Firestone Gregory A. Chief Business Officer | 2026-02-24 20:00:20 | 194,307 0 | 194,307 | Form 4 |
| 14 | Langstein Howard N. Chief Medical Officer | 2026-03-11 16:05:01 | 144,097 0 | 144,097 | Form 3 |
| 15 | PERSENAIRE MAARTEN Chief Medical Officer | 2021-02-26 17:27:45 | 112,687 0 | 112,687 | Form 4 |
| 16 | Capper Joseph H Director | 2026-09-16 18:46:42 | 104,827 0 | 104,827 | Form 4 |
| 17 | Smeykal Megan Chief Accounting Officer | 2026-02-24 20:00:13 | 66,873 0 | 66,873 | Form 4 |
| 18 | Murphy Peter C. Chief Commercial Officer | 2024-04-02 19:42:50 | 48,129 0 | 48,129 | Form 4 |
| 19 | Plovanic William J. Director | 2026-07-17 17:30:07 | 44,530 0 | 44,530 | Form 4 |
| 20 | Rocchio Betty Jo Director | 2026-06-11 18:14:21 | 40,935 0 | 40,935 | Form 4 |
| 21 | Burgess Vincent J Director | 2025-05-30 16:15:24 | 35,030 0 | 35,030 | Form 4 |
| 22 | EVANS DOUGLAS G Director | 2025-05-30 16:18:35 | 30,170 0 | 30,170 | Form 4 |
| 23 | Azarbarzin Kurt Director | 2025-05-30 16:17:55 | 30,170 0 | 30,170 | Form 4 |
| 24 | COLLERAN LISA N Director | 2025-05-30 16:14:50 | 30,170 0 | 30,170 | Form 4 |
| 25 | O'Brien Federica F. Director | 2025-05-30 16:18:27 | 30,170 0 | 30,170 | Form 4 |
| 26 | Greenhalgh Ellis Skott Chief Technology Officer | 2022-02-28 16:24:06 | 27,826 0 | 27,826 | Form 4 |
| 27 | Quaker BioVentures II LP Quaker BioVentures Capital II L.P. 10% Owner | 2022-06-23 06:31:45 | 18,096 0 | 18,096 | Form 13G |
| 28 | Brennan Nora Chief Financial Officer | 2021-04-02 14:41:14 | 17,696 0 | 17,696 | Form 4 |
| 29 | Nosenzo John Director | 2023-06-02 16:36:54 | 11,630 0 | 11,630 | Form 4 |
| 30 | Oliva Adele C Director | 2020-06-08 16:38:42 | 8,806 0 | 8,806 | Form 4 |
| 31 | THOMAS PAUL Director | 2026-06-11 18:06:56 | 0 0 | 0 | Form 3 |
| 32 | NEELS GUIDO J Director | 2026-06-11 18:08:15 | 0 0 | 0 | Form 3 |
| 33 | NOHRA GUY P Director | 2026-06-11 18:05:11 | 0 0 | 0 | Form 3 |